Intensive Care Clinical Trial
— qSOFASTOfficial title:
Usefulness of Routine qSOFA Calculation at Triage to Fasten Antimicrobial Administration in Patients With Bacterial Infection in the Emergency Department: a Quasi-experimental Study
Verified date | July 2018 |
Source | Centre Hospitalier Régional d'Orléans |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The delayed administration of an adequate antimicrobial therapy is a strong predictor of
impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis
Campaign guidelines (2016) recommend that administration of intravenous antimicrobials be
initiated within one hour following the recognition of sepsis or septic shock.
The quick Sepsis-related Organ Failure Assessment (qSOFA) score is a new bedside tool which
has been recently proposed by the Third International Sepsis Consensus Definitions Task Force
(Sepsis-3) to identify patients with suspected infection who are at greater risk for a poor
outcome outside the Intensive Care Unit (ICU). It uses three criteria, assigning one point
for low systolic blood pressure (SBP ≤100 mmHg), high respiratory rate (≥22 breaths per min)
and altered mentation (Glasgow coma scale <15). The score ranges from 0 to 3 points. A qSOFA
value ≥2 points is associated with a greater risk of death or prolonged ICU stay, these
outcomes being more common in infected patients who may be septic than in those with
uncomplicated infection. The definite goal of qSOFA is to hasten the management and thus
improve the outcome of patients at risk of sepsis or septic shock.
Many patients admitted to the hospital for bacterial sepsis or septic shock are initially
managed in the Emergency Department (ED). This study aims at investigating whether the
routine calculation of qSOFA at patient triage may hasten the initiation of antimicrobial
therapy in patients admitted to the ED with suspected or proven bacterial infection,
especially in those with subsequent criteria for sepsis or septic shock (Sepsis-3
definition).
Status | Completed |
Enrollment | 780 |
Est. completion date | June 10, 2018 |
Est. primary completion date | June 10, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 105 Years |
Eligibility |
Inclusion Criteria: • Suspected or proven bacterial infection at emergency department triage Exclusion Criteria: - Imminent death - Pregnancy - Breast-feeding - For patients managed by a medicalized pre-hospital emergency team before ED admission : administration of a first dose of antimicrobial agent before ED admission - Lack of coverage by the public health insurance system - Patient's refusal for study enrollment - Lack of confirmed bacterial infection (i.e., documented either clinically, microbiologically or by imaging procedures) in patients with a suspected bacterial infection at emergency departement triage |
Country | Name | City | State |
---|---|---|---|
France | Regional Hospital center of Orleans | Orléans |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Régional d'Orléans |
France,
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients who receive a first dose of antimicrobial agent | Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within one hour following triage in the emergency department. | one hour | |
Secondary | Proportion of patients who receive a first dose of adequate antimicrobial agent | Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) and microbiologically documented infection who receive a first dose of adequate antimicrobial agent within one hour following triage in the emergency department. | one hour | |
Secondary | Proportion of patients who receive a first dose of antimicrobial agent | Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within 3 hours following triage in the emergency department. | three hours | |
Secondary | Proportion of patients who receive a first dose of adequate antimicrobial agent | Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) and a microbiologically documented infection who receive a first dose of adequate antimicrobial agent within 3 hours following triage in the emergency department | three hours | |
Secondary | Proportion of patients with a decrease in SOFA score value = 1 point | Proportion of patients with a decrease in SOFA score value = 1 point between triage in the emergency department (Day 0) and Day 2 among those with an initial SOFA score value = 1 point | two days | |
Secondary | Proportion of patients requiring an admission to the Intensive Care Unit | Proportion of patients requiring an admission to the Intensive Care Unit between triage in the emergency department (Day 0) and Day 2 | two days | |
Secondary | In-hospital mortality at day 7 | Number of patients who died in hospital at day 7 | seven days | |
Secondary | Overall In-hospital mortality | Number of patients who died in hospital during the hospital stay | through hospital discharge, up to 3 months | |
Secondary | Length of hospital stay | Number of days in hospital | throught hospital discharge, up to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00487097 -
The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients
|
N/A | |
Completed |
NCT01997931 -
The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients
|
N/A | |
Recruiting |
NCT04926220 -
Dynamic Estimation of Cardiac Output in the Operating Room
|
||
Not yet recruiting |
NCT03617796 -
Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
|
||
Withdrawn |
NCT04554264 -
Complicated Grief in ICU in the Aftermath of COVID-19
|
N/A | |
Recruiting |
NCT02587273 -
The Pharmacokinetics of Fentanyl in Intensive Care Patients
|
Phase 4 | |
Withdrawn |
NCT01749488 -
The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care
|
N/A | |
Recruiting |
NCT06110390 -
High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients
|
N/A | |
Completed |
NCT04186611 -
Early Occupational Therapy in Intensive Care: Feasibility of Implementation
|
N/A | |
Recruiting |
NCT03777150 -
Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients?
|
N/A | |
Completed |
NCT02583321 -
Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate
|
N/A | |
Completed |
NCT00787098 -
Investigating Modes of Progressive Mobility
|
Phase 2 | |
Recruiting |
NCT04114747 -
Renal Physiology During Continuous Renal Replacement Therapy
|
N/A | |
Completed |
NCT02476591 -
Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care
|
N/A | |
Completed |
NCT05795777 -
Examination of the Pressure Ulcers in Intensive Care Patients.
|
||
Terminated |
NCT02587130 -
Ketamine and Refractory Painful Care in a Palliative Unit
|
Phase 4 | |
Completed |
NCT02463123 -
Energy Expenditure Estimation in Cardiac Surgery
|
N/A | |
Completed |
NCT01607723 -
"NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes
|
Phase 3 | |
Completed |
NCT01346813 -
Epidemiology of Painful Procedures in Neonates
|
N/A | |
Completed |
NCT00410852 -
Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients
|
N/A |